MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

Meeting: 2022 International Congress

Abstract Number: 737

Keywords: Parkinsonism

Category: Parkinson’s Disease: Clinical Trials

Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson’s disease.

Background: Currently, clinical genetics has a number of methods for obtaining information to identify patterns inherent in hereditary diseases. The genealogical analysis is one of the affordable and cost-effective methods, which often plays an important role in the prediction, diagnosis, and adequate therapy of diseases.

Method: The study included 213 patients with PD, 90 women, 123 men, whose average age was 46.17 ± 0.63 years, mainly of Uzbek nationality. A control group of 20 healthy people of Uzbek nationality of the same age without signs of PD. PD patients were selected in accordance with the international criteria of the British Brain Bank “Parkinson’s Disease Society Brain Bank”. To exclude other causes of Parkinson’s syndrome, patients underwent CT or MRI of the brain. In PD patients, the form of the disease (akinetic-rigid, mixed, or tremulous) and the functional stage of the disease (according to the Hoehn-Yahr scale) were assessed.

Results: Due to the supposed differences in the pathogenesis of early and late forms of PD, the main group was into subgroups based on the age of onset of the disease. The subgroup of early parkinsonism consisted of 79 patients in whom the symptoms of the disease manifested before the age of 45, and 76 patients with a burdened family history (it is in these categories of patients that the probability of detecting mutations is maximal), the subgroup of late parkinsonism accounted for 58 patients with an age of onset of primary parkinsonism> 45 years. A detailed pedigree was compiled, which included information about diseases in 2-3 generations of the family. A total of 1741 people were analyzed in the model population.  A burdened family history of PD was observed in 76 cases, 44 men, 32 women. In families of probands, PD in generations in relation to the total number of patients with each concentration is III – 16; II- 23; I- 37. The burden in the population of practically healthy people was observed much less: III – 0%; II – 0%; I- 0%.

Conclusion: It turned out that PD is more often affected by relatives of the I degree of kinship 37, which in relation to the total number of patients with this concentration is 35.68%, and men accounted for 44 cases. In one case, there was a burdened family history of PD, with early-onset at 45 years of age, and two-family cases with PD in a cousin and a sister.

To cite this abstract in AMA style:

S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova. CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-and-geneological-features-of-parkinsons-disease/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-geneological-features-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley